(Q41138258)

27 September 2017

title

The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

3 November 2022

1 reference

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703780

3 November 2022

author name string

S. J. Cooper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703780

3 November 2022

W. Leahey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703780

3 November 2022

J. Liddle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703780

3 November 2022

D. J. King

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703780

3 November 2022

language of work or name

English

0 references

publication date

1 July 1990

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:092099649090007T?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

https://api.elsevier.com/content/article/PII:092099649090007T?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

3 November 2022

published in

Schizophrenia Research

1 reference

27 September 2017

volume

3

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

261-267

1 reference

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

27 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Central dopamine turnover in schizophrenic syndromes.

3 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Plasma monoamine metabolites in psychotic disorders

3 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment

3 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Brain homovanillic acid: Regional changes over time with antipsychotic drugs

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

3 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

3 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

3 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection

3 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Molecular pathology of schizophrenia: more than one disease process?

3 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Plasma homovanillic acid as a predictor of response to neuroleptics

3 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Diagnostic Criteria for Use in Psychiatric Research

3 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

3 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Tolerance to tyrosine hydroxylase activation in N. Accumbens and C. Striatum after repeated injections of “classical” and “atypical” antischizophrenic drugs

3 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum

3 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

3 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

3 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Estimation of catecholamines in urine by high performance liquid chromatography with electrochemical detection

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

A standardized psychiatric assessment scale for rating chronic psychotic patients

3 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol

3 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.

3 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Plasma and CSF HVA before and after pharmacological treatment

3 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Mode of action of antidepressant drugs

3 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

3 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

A simple and reliable subclassification of chronic schizophrenia

3 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment

3 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0920-9964(90)90007-T

3 November 2022

Identifiers

1 reference

27 September 2017

1 reference